在医疗保健工作人员中进行潜在结核病查计划的成本效益分析
Niludi Ranwanee Yasaratna1,2, Manuj Chrishantha Weerasinghe1
1University of Colombo, Colombo, Sri Lanka.
概括
在斯里兰卡,对医疗保健人员进行潜伏结核病感染 (LTBI) 查是非常具有成本效益的. 该计划以2381.29美元的速度避免了残疾调整寿命年 (DALYs),使其成为消除结核病努力的推策略.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- 潜伏性结核病感染 (LTBI) 查对于全球结核病 (TB) 消除至关重要,因为结核病菌的大量储备.
- 斯里兰卡在2022年启动了一项针对高风险群体的结核病管理计划,包括医疗人员,观察到18%的LTBI流行率.
研究的目的:
- 评估实施专门针对斯里兰卡医疗保健人员的LTBI查计划的成本效益.
- 确定是否对医疗保健人员进行LTBI查是国家结核病控制倡议中的经济可行策略.
主要方法:
- 从卫生系统的角度开发了一个决策树模型,使用2021-2022年的二次数据.
- 该模型评估了与LTBI测试,预防和潜在和活跃结核病病例的管理相关的成本.
- 计算了增量成本效益比率 (ICER),并与已确定的成本效益值进行了比较.
主要成果:
- 管理一个活跃的结核病例的成本 (80.44美元) 比管理一个LTBI病例 (20.84美元) 高得多.
- 查计划的增量成本效益比 (ICER) 为每次残疾调整寿命年 (DALY) 2381.29美元.
- 针对医疗保健人员的LTBI查显示出有利的成本效益概况.
结论:
- 实施斯里兰卡医疗保健人员的LTBI查是一种非常具有成本效益的干预措施.
- 这些发现支持推和扩展这一查计划,作为国家结核病消除战略的一部分.
- 投资对像医疗保健工作者这样的高风险群体进行LTBI查对于有效的结核病控制至关重要.
相关概念视频
Pulmonary Tuberculosis IV
128
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
128
Pulmonary Tuberculosis V
166
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
166
Pulmonary Tuberculosis II
210
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
210
Pulmonary Tuberculosis I
218
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
218
Pulmonary Tuberculosis III
291
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
291
Statistical Methods for Analyzing Epidemiological Data
284
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
284


